These data suggest that NTS signaling through NTSR1 is the major mediator of maladaptive fat metabolism in MASLD, whereas NTSR3 most likely plays a supportive role. The gene discussed is NTSR1; the disease is metabolic dysfunction-associated steatotic liver disease.